Live Long and Prosper: Aging Research in Academia and Industry

But recently scientists have begun to unravel the biological basis of aging with fascinating results, providing insight into how age-related diseases are influenced by life-style choices and medicine. But can aging itself become a therapeutic target? What are the recent key discoveries in biomedical aging research and what can we learn from them to live longer and healthier? How does the pharmaceutical industry position itself in light of aging societies? What are the breakthroughs on the horizon? This public panel discussion with German and American experts will explore the current approaches and trends in academic research on aging as well as pharmaceutical R&D investments into new treatments of aging-related diseases.

This event is part of the “Aging and Society” series organized by the University of Cologne New York Office and the German Center for Research and Innovation.

Watch the panel discussion with:

Björn Schumacher, Ph.D.
Director of the Institute for Genome Stability in Aging and Disease,
CECAD Cluster of Excellence, University of Cologne,
President of the German Society for Aging Research (DGfA)

James Peyer, Ph.D.
Managing Partner, Apollo Ventures

Jan Vijg, Ph.D.
Chair, Department of Genetics, Albert Einstein College of Medicine

moderated by
Molly MacLeod, Ph.D.
Senior Manager, Science Content, Communications,
Pfizer Worldwide Research & Development